Author

Wen‐Ming Cao

The University of Texas MD Anderson Cancer CenterORCID 0000-0002-5644-3156Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Chunchao ZhangiD· 1 shared Edaise M. da SilvaiD· 1 shared Feng ChengiD· 1 shared Higinio DopesoiD· 1 shared Hong ZhangiD· 1 shared Hui CheniD· 1 shared Jianhua YangiD· 1 shared Jinling Yi· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chunchao ZhangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer LettersPeer-reviewedMay 30, 2023

FOXK2 amplification and overexpression promotes breast cancer development and chemoresistance

Yang Yu, Wen‐Ming Cao, Feng Cheng…·Hong Zhang

This study identifies FOXK2 amplification and overexpression in breast cancer, showing its role in promoting tumor growth, chemoresistance, and synergistic therapeutic responses when targeted with PI3KCA inhibitors.

11 citations

humanbulk RNA-seq

𝕏 PostBluesky